Elevance Health, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Elevance Health, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2010 to Q3 2024.
  • Elevance Health, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $1.02B, a 21.2% decline year-over-year.
  • Elevance Health, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $6.42B, a 7.04% increase year-over-year.
  • Elevance Health, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $5.99B, a 1.58% increase from 2022.
  • Elevance Health, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $5.89B, a 4.29% decline from 2021.
  • Elevance Health, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $6.16B, a 34.7% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $6.42B $1.02B -$273M -21.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-17
Q2 2024 $6.69B $2.3B +$447M +24.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-17
Q1 2024 $6.24B $2.25B +$257M +12.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-18
Q4 2023 $5.99B $856M -$9M -1.04% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 $6B $1.29B -$314M -19.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-17
Q2 2023 $6.31B $1.85B +$216M +13.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-17
Q1 2023 $6.09B $1.99B +$200M +11.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-18
Q4 2022 $5.89B $865M -$326M -27.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 $6.22B $1.6B +$94M +6.23% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-18
Q2 2022 $6.13B $1.64B -$156M -8.7% Apr 1, 2022 Jun 30, 2022 10-Q/A 2023-09-29
Q1 2022 $6.28B $1.79B +$124M +7.45% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-19
Q4 2021 $6.16B $1.19B +$640M +116% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-21
Q3 2021 $5.52B $1.51B +$1.29B +580% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-19
Q2 2021 $4.23B $1.79B -$483M -21.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-20
Q1 2021 $4.71B $1.67B +$142M +9.32% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-20
Q4 2020 $4.57B $551M -$383M -41% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-18
Q3 2020 $4.96B $222M -$961M -81.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-20
Q2 2020 $5.92B $2.28B +$1.14B +99.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-21
Q1 2020 $4.78B $1.52B -$28M -1.81% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-21
Q4 2019 $4.81B $934M +$510M +120% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-18
Q3 2019 $4.3B $1.18B +$223M +23.2% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-18
Q2 2019 $4.07B $1.14B +$85M +8.07% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-18
Q1 2019 $3.99B $1.55B +$239M +18.2% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-18
Q4 2018 $3.75B $424M -$808M -65.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-19
Q3 2018 $4.56B $960M +$213M +28.5% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-19
Q2 2018 $4.35B $1.05B +$199M +23.3% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-19
Q1 2018 $4.15B $1.31B +$303M +30% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-19
Q4 2017 $3.84B $1.23B +$864M +234% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-20
Q3 2017 $2.98B $747M +$129M +20.9% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-20
Q2 2017 $2.85B $855M +$74.4M +9.53% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-20
Q1 2017 $2.78B $1.01B +$306M +43.5% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-20
Q4 2016 $2.47B $368M +$188M +104% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-21
Q3 2016 $2.28B $618M -$37M -5.65% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-21
Q2 2016 $2.32B $781M -$78.5M -9.14% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-21
Q1 2016 $2.4B $703M -$162M -18.7% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-21
Q4 2015 $2.56B $181M -$326M -64.3% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-22
Q3 2015 $2.89B $655M +$23.9M +3.79% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-22
Q2 2015 $2.86B $859M +$128M +17.5% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-22
Q1 2015 $2.73B $865M +$164M +23.4% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-22
Q4 2014 $2.57B $507M +$359M +242% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-19
Q3 2014 $2.21B $631M -$25.3M -3.86% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-19
Q2 2014 $2.24B $731M -$69M -8.62% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-19
Q1 2014 $2.31B $701M -$184M -20.8% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-19
Q4 2013 $2.49B $148M -$316M -68.1% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-24
Q3 2013 $2.81B $656M -$35M -5.06% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-24
Q2 2013 $2.84B $800M +$157M +24.3% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-24
Q1 2013 $2.68B $885M +$28.7M +3.35% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-24
Q4 2012 $2.66B $464M +$129M +38.4% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-20
Q3 2012 $2.53B $691M +$8M +1.17% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-20
Q2 2012 $2.52B $644M -$58M -8.27% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-20
Q1 2012 $2.58B $857M -$70.1M -7.57% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-20
Q4 2011 $2.65B $335M -$214M -38.9% Oct 1, 2011 Dec 31, 2011 10-K 2013-02-22
Q3 2011 $2.86B $683M -$55.9M -7.56% Jul 1, 2011 Sep 30, 2011 10-K 2013-02-22
Q2 2011 $2.92B $702M -$20.8M -2.88% Apr 1, 2011 Jun 30, 2011 10-K 2013-02-22
Q1 2011 $2.94B $927M +$49.8M +5.68% Jan 1, 2011 Mar 31, 2011 10-K 2013-02-22
Q4 2010 $2.89B $549M Oct 1, 2010 Dec 31, 2010 10-K 2012-02-22
Q3 2010 $739M Jul 1, 2010 Sep 30, 2010 10-K 2012-02-22
Q2 2010 $722M Apr 1, 2010 Jun 30, 2010 10-K 2012-02-22
Q1 2010 $877M Jan 1, 2010 Mar 31, 2010 10-K 2012-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.